Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: 2 | Rare Historical Photos

IQVIA Holdings Stock Outlook: Is Wall Street Bullish or Bearish?

IQVIA Holdings has underperformed the broader market this year, but Wall Street analysts are bullish about the stock’s prospects.

How Is IQVIA Holdings' Stock Performance Compared to Other Healthcare Stocks?

How Is IQVIA Holdings' Stock Performance Compared to Other Healthcare Stocks?

IQVIA Holdings has underperformed other healthcare stocks over the past three months, but analysts are optimistic about the stock’s prospects.

Are These 3 Medical Stocks Worth Buying?

Are These 3 Medical Stocks Worth Buying?

The increased demand for healthcare services and technological advancements are poised to keep the healthcare industry buoyed in the foreseeable future. Given this backdrop, are medical stocks Danaher Corporation (DHR), IQVIA Holdings (IQV), and Bio-Rad Laboratories (BIO) worth buying now? Read on to find more….

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

5 Hard-Hit Large-Cap Stocks Ready to Rebound

The market turmoil this year, due to the sky-high inflation and the Fed’s hawkish tilt, has led several fundamentally solid large-cap stocks to trade below their intrinsic values. However, we believe quality large-cap stocks Broadcom (AVGO), Abbott (ABT), IQVIA (IQV), Agilent (A), and QUALCOMM (QCOM), which have declined significantly in…

Better Buy: IQVIA Holdings vs. Mettler-Toledo

Integration of advanced technologies and analytics in diagnosing chronic diseases at their early stages has helped the medical diagnostics and research industry grow substantially over the past few years. Growing demand and rising investments in R&D should help prominent players in this space, IQVIA Holdings (IQV) and Mettler-Toledo (MTD), benefit.…

Investors Seem To Be Unmoved By IQVIA's Street Lagging Estimates, Q1 Surpass Expectations

IQVIA Holdings Inc (NYSE:IQV) posted Q1 sales of $3.57 billion, up 4.7% on a reported basis and 6.8% at constant currency (CC), slightly above the consensus of $3.55 billion. Technology & Analytics Solutions revenue increased 6.8% (9.8% CC) to $1.44 billion. Research & Development Solutions (R&DS) sales reached $1.93 billion, +3.5% (4.7%…

3 Cloud Computing Stocks to Buy Now

The cloud computing market is expanding as companies innovate and find new ways to incorporate advanced technologies in their operations. Since the cloud computing industry is expected to grow tremendously in the coming years, we think it could be wise to bet now on quality stocks IQVIA Holdings (IQV), F5…

inkl

Read news from The Economist, FT, and more,
with one subscription

IQVIA: Q1 Earnings Insights

IQVIA: Q1 Earnings Insights

IQVIA Hldgs (NYSE:IQV) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Analyst Ratings for IQVIA Hldgs

Analyst Ratings for IQVIA Hldgs

Over the past 3 months, 6 analysts have published their opinion on IQVIA Hldgs (NYSE:IQV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

3 Beaten-Down Growth Stocks to Snatch Up in Q2 2022

3 Beaten-Down Growth Stocks to Snatch Up in Q2 2022

Despite no clarity on when the Russia-Ukraine war will end, surging inflation, and logistical hindrances, the U.S. economy looks sufficiently resilient to weather the crises. Given this backdrop, we think shares of beaten-down growth stocks IQVIA (IQV), West Pharmaceutical (WST), and Synopsys (SNPS) could soar in price in the coming…

Analyst Ratings For IQVIA Hldgs

Analyst Ratings For IQVIA Hldgs

Within the last quarter, IQVIA Hldgs (NYSE:IQV) has observed the following analyst ratings:

Death Cross Looms Over IQVIA Hldgs Investors

Death Cross Looms Over IQVIA Hldgs Investors

If history is any guide, there may be trouble ahead for shares of IQVIA Hldgs (NYSE:IQV). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

IQVIA Holdings' Q4 Beats Street View, Lifts FY22 Earnings Guidance

IQVIA Holdings' Q4 Beats Street View, Lifts FY22 Earnings Guidance

IQVIA Holdings Inc (NYSE: IQV) has posted

Recap: IQVIA Holdings Q4 Earnings

Recap: IQVIA Holdings Q4 Earnings

IQVIA Holdings (NYSE:IQV) reported its Q4 earnings results on Tuesday, February 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Get all your
news in one place.

100's of premium titles.
One news app.

A Preview Of IQVIA Holdings's Earnings

IQVIA Holdings (NYSE:IQV) is set to give its latest quarterly earnings report on Tuesday, 2022-02-15. Here's what investors need to know before the announcement. Analysts estimate that IQVIA Holdings will report an earnings per share (EPS) of $2.43.

CNBC's Final Trades: Iqvia, Nvidia, Wynn Resorts And This ETF

On CNBC’s “Halftime Report Final Trades,” Shannon Saccocia of Boston Private said Iqvia Holdings Inc (NYSE: IQV) works with “life sciences companies to help deliver positive end points in trials thro

1 2

People

Steve Reitmeister

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Abbott Laboratories

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

383,947 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play